Recnac

Sangeeta Sunny Chettiath

Sangeeta Sunny Chettiath

About Sangeeta Sunny Chettiath

MPH / Ohio University / Resident Blogger @TraffickFree

Sangeeta Sunny Chettiath

Latest Posts

Dopamine: The Poor Man's Cure

We usually hear about dopamine in terms of neurotransmitters like epinephrine (adrenaline), serotonin, and histamine. But dopamine is also a treatment for circulatory problems caused by heart attack, heart failure, kidney failure, low blood pressure, or surgery. Earlier this year researchers at The ...

Trending: Cancer and Your Diet

The internet answers all our questions, but no one said the answers were accurate. As consumers of a seemingly infinite world wide web it’s hard to determine what is and is not a credible source. Here are curated answers to some of the most "Googled" questions about cancer and diet. ...

Top 4 Moments for Cancer Research in 2014

2014 was another year for excellence in medicine - and especially for cancer treatment and screening. Here are four successful feats of medical research that will revolutionize what it means to be diagnosed with cancer.Expansion of the Genetic AlphabetRemember DNA base pairs? Adenine, Guanine, Cyto ...

Why More Black Women Die of Breast Cancer

The mortality rate for breast cancer in the United States, according to the American Cancer Society, has decreased to 15%. This significant drop is a result of education, screening, and treatment. Not all women, however, are equally benefiting from these advances. The CDC reports that black wo ...

Cancer Survivorship in Public Health

In January, 2014, there were 14.5 million children and adults in the Unites States living with a history of cancer, according to the American Cancer Society. By 2024, the ACS estimates that number will reach 19 million. This increasing survivorship is a result of innovations in medical technologies ...

FDA Approves Cancer Screening in a Box

The demand for reducing the cost of healthcare is fostering a new generation of accessibility. According to the National Institutes of Health (NIH), the FDA recently approved optical imaging devices, for oral cancers, developed by bioengineers at Rice University. The team explains, in the Journal o ...